Brought to you by 
Aastrom nets $23.9mm with private placement
12 Apr 2006
Executive Summary
Cell therapy company Aastrom Biosciences netted $23.9mm through the private placement of 15.9mm common shares at $1.60 (a 20% discount) to institutional investors. Merriman Curhan Ford acted as the placement agent. The company will use the proceeds to continue clinical development on its cell therapy product candidates designed using the tissue repair cell (TRC) adult stem cell technology.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aastrom nets $23.9mm with private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice